Momeny, Majid <br/><br/>
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.  [electronic resource] 

 -  Scientific reports  03 2017 
 - 44075 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep44075  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anoikis<br/>Antineoplastic Agents--therapeutic use<br/>Brain Neoplasms--complications<br/>Cell Adhesion<br/>Cell Cycle Checkpoints<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Gefitinib<br/>Glioblastoma--complications<br/>Humans<br/>Neovascularization, Pathologic--complications<br/>Phenylurea Compounds--therapeutic use<br/>Quinazolines--therapeutic use<br/>Quinolines--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors